μPADs for a Safer Night's Sleep: An Alternative for Quality Control of Melatonin Pharmaceutical Formulations
Abstract
Melatonin, known as the "sleep hormone," has its primary function in regulating the circadian cycle, a 24 h sleep-wake pattern that leads to significant physical, mental, and behavioral changes. The use of melatonin in pharmaceutical formulations gained popularity as a tool to combat sleep disorders such as insomnia and has been increasing in the last few decades. Melatonin-based pharmaceutical formulations are classified as dietary supplements, which leads to a different perspective on the necessity of strict quality control for these products. There are already extensive descriptions in the literature of the serious side effects associated with the administration of those formulations, including, for example, higher dosages than indicated on the label or contamination by other hormones. Still, there is a gap in devices that could make an easy and low-cost determination of melatonin. This work presents a paper-based sensor for the quality control of melatonin in pharmaceutical formulations, utilizing the modified Van Urk reaction. This reaction causes a color change from white to blue on the paper surface, correlating with the melatonin concentration. The constructed sensor performed well in quantifying melatonin in solid (0.22 mg/tablet) and liquid (0.20 mg/drop) pharmaceutical formulations, considering the maximum standard deviation when compared with results obtained by a gold-standard technique (liquid chromatography). The developed method demonstrated good linearity…
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.